We are a small team led by two researchers at the University of Oslo and Oslo University Hospital with a keen interest in drug discovery and metabolic disorders. Together with team colleagues we aim to design novel drugs for restoring metabolic imbalance in rare inborn metabolic diseases.
“We aim to develop a novel drug to answer the unmet need for patients living with rare metabolic disorders and to improve their quality of life.”
Prof. Lars Eide
The drug program is currently at the discovery stage with strong biochemical data.
“Our drug program aims to develop novel chemical compounds that will make it all the way to the patients for their benefits.”
Dr. Scient. Bjørn Dalhus